Endovia Health Sciences: CannEpil qualifies as minor use for canine bone cancer

What happened Endovia Health Sciences announced in a Form 8-K filed Oct 5, 2026 that the U.S. Food and Drug Administration determined that CannEpil qualifies as a minor use for canine bone cancer pain. The company issued a press release announcing the determination and furnished that press release as Exhibit 99.1 to the Form 8-K.

Key details

• The company announced the FDA determination on Oct 5, 2026.
• The announcement was made via a press release furnished as Exhibit 99.1 to this Current Report on Form 8-K.
• The disclosure was reported under Item 7.01, Regulation FD disclosure.

Why it may matter This Form 8-K reports Item 7.01, regulation FD disclosure, which covers public announcements of material information through channels such as press releases. The filing does not show why the company acted or why any insider traded.